Form 4: P&G CFO Andre Schulten Awarded Equity
Insider Transaction Report
Procter & Gamble's Chief Financial Officer, Andre Schulten, was awarded 5,602 restricted stock units and 77,648 stock options on October 1, 2025.
Summary
- Andre Schulten, Chief Financial Officer of Procter & Gamble Co (PG), reported changes in his beneficial ownership of company securities.
- On October 1, 2025, Schulten was awarded 5,602 shares of Common Stock in the form of Restricted Stock Units (RSUs) at a transaction price of $0.
- These RSUs were granted pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan.
- He also acquired 77,648 Stock Options with an exercise price of $153.18, also at a transaction price of $0.
- The acquired stock options have an exercisable date of September 29, 2028, and an expiration date of October 1, 2035.
- Following these transactions, Schulten directly owns 58,244.0273 shares of Common Stock and 77,648 Stock Options.
- An adjustment to the PST through September 30, 2025, resulted in 6,870.6545 shares of Common Stock beneficially owned indirectly via a Retirement Plan Trustee.
Sentiment
Score: 7
Explanation: The filing reports a significant equity award to a key executive, which is a positive sign of management alignment with shareholder interests and confidence in future company performance, typical of executive compensation plans.
Positives
- Chief Financial Officer Andre Schulten received a significant equity award, including 5,602 Restricted Stock Units and 77,648 Stock Options, which aligns his interests with those of shareholders.
- The equity awards demonstrate the company's commitment to executive incentive compensation, linking management performance to long-term shareholder value creation.
Future Outlook
The filing does not contain explicit forward-looking statements or guidance, as it primarily reports an insider transaction related to executive compensation.
Industry Context
This filing reports a routine executive compensation event for a major consumer goods company. Such equity awards are standard practice across industries to incentivize and retain key management personnel, aligning their financial interests with the company's long-term performance and shareholder returns.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Compensation Plan Utilization | Equity awards (Restricted Stock Units and Stock Options) were granted under The Procter & Gamble 2019 Stock and Incentive Compensation Plan. | 10/01/2025 | Demonstrates the ongoing implementation of the company's approved executive compensation framework, aligning executive incentives with long-term shareholder value. |
Stakeholder Impact
- Shareholders: The equity awards align the Chief Financial Officer's financial incentives with the long-term performance and value creation for shareholders.
Next Steps
- The acquired stock options will become exercisable on September 29, 2028, and will expire on October 1, 2035.
Key Dates
| Date | Description |
|---|---|
| 10/01/2025 | Date of earliest transaction, including the acquisition of Restricted Stock Units and Stock Options. |
| 10/02/2025 | Date the Form 4 filing was signed. |
| 09/29/2028 | Date the acquired Stock Options become exercisable. |
| 10/01/2035 | Expiration date of the acquired Stock Options. |
Recommendation
holdThis Form 4 reports routine executive compensation in the form of restricted stock units and stock options. While it indicates management's continued alignment with shareholder interests, it does not present new fundamental information that would alter an existing investment thesis for Procter & Gamble. Therefore, a 'hold' recommendation is appropriate, maintaining current positions based on broader company performance and market conditions.
Keywords
Procter & Gamble, PG, Andre Schulten, CFO, Form 4, Insider Transaction, Equity Award, Restricted Stock Units, Stock Options, Executive Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.